What the Biopharmaceutical Industry Needs to Know in the Wake of the Supreme Court Decision Upholding the Affordable Care Act

No Worries, We Recorded it Will the PhRMA Deal Stand and What Happens Next? What the Biopharmaceutical Industry Needs to Know in the Wake of the Supreme Court Decision Upholding the Affordable Care Act July 26 This 90-minute archived webinar lets you hear experts cut through the hype to consider the real effects of the decision on the drug, device and biopharmaceutical industries. Among other things, panelists discussed how states may limit the expansion of Medicaid and how that may affect the PhRMA deal with Congress, including the $80 Billion contribution in exchange for additional patients with Part D coverage. At the conclusion of this webinar, you will be able to: • Explain the effects of the Affordable Care Act decision on the medicine companies, especially its affect on Medicare Part D covered recipients and the biopharmaceutical industries • Discuss how the decision may impact the development of biosimilars • Discuss the options and possible political outcomes as health care reform evolves, including likely legislation next year important to the biopharmaceutical and related industries Moderator: • John F. Kamp, JD, PhD, Executive Director Coalition for Healthcare Communication Presenters: • Peter J. Pitts, President, Center for Medicine in the Public Interest • Arnold I. Friede, Former FDA Associate Chief Counsel, Principal, Arnold I. Friede & Associates • Richard Manning, PhD, Partner, Bates White Economic Consulting Please Note: Continuing education credits are not available for archived webinars. Overview | Register The Patient-Centered Outcomes Research Institute’s National Priorities and Research Agenda Biosimilar Guidances: Explanation and Discussion: Part 1 and Part 2 Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch Two-part Series: Impact of the New European Pharmacovigilance Legislation on International Companies View the Full List of Archived Webinars. Questions on Archived Webinars? Contact: Carolyn Callahan